These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 21479134

  • 1. IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.
    Lin CY, Chen JY, Lin TN, Jeng WJ, Huang CH, Huang CW, Chang SW, Sheen IS.
    PLoS One; 2011 Mar 30; 6(3):e18322. PubMed ID: 21479134
    [Abstract] [Full Text] [Related]

  • 2. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
    Rallón NI, Soriano V, Naggie S, Restrepo C, Goldstein D, Vispo E, McHutchison J, Benito JM.
    AIDS; 2011 May 15; 25(8):1025-33. PubMed ID: 21505315
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM, García-Samaniego J, García M, Madejón A, Martín-Carbonero L, Cabello A, Álvarez B, Górgolas M, Rallón N.
    J Interferon Cytokine Res; 2017 Jun 15; 37(6):278-286. PubMed ID: 28440692
    [Abstract] [Full Text] [Related]

  • 5. None of the six SNPs of IL28B could predict treatment responses in genotype 2 chronic HCV infected patients by propensity score matching analysis.
    Jeng WJ, Lin CY, Chen JY, Huang CW, Huang CH, Sheen IS.
    PLoS One; 2012 Jun 15; 7(11):e48217. PubMed ID: 23173032
    [Abstract] [Full Text] [Related]

  • 6. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F, Ghazanfari M, Vaziri F, Jamnani FR, Davari M, Gharibzadeh S, Fateh R, Abdolrahimi F, Dizaji SP, Fateh A, Siadat SD.
    Infect Genet Evol; 2017 Oct 15; 54():330-337. PubMed ID: 28739427
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
    Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J, Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D, Mozer-Lisewska I, Januszkiewicz-Lewandowska D.
    World J Gastroenterol; 2017 Jun 07; 23(21):3815-3824. PubMed ID: 28638221
    [Abstract] [Full Text] [Related]

  • 8. Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients.
    Aghemo A, Degasperi E, Rumi MG, Galmozzi E, Valenti L, De Francesco R, De Nicola S, Cheroni C, Grassi E, Colombo M.
    Biomed Res Int; 2013 Jun 07; 2013():580796. PubMed ID: 23936821
    [Abstract] [Full Text] [Related]

  • 9. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM, Nemr NA, Kishk RM, Mandour MF, Abdou MM, Matsuura K, Watanabe T, Tanaka Y.
    Liver Int; 2014 Jul 07; 34(6):890-5. PubMed ID: 24102823
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.
    Liu CH, Liang CC, Liu CJ, Tseng TC, Lin CL, Yang SS, Su TH, Hsu SJ, Lin JW, Chen JH, Chen PJ, Chen DS, Kao JH.
    Antivir Ther; 2012 Jul 07; 17(3):477-84. PubMed ID: 22301466
    [Abstract] [Full Text] [Related]

  • 11. Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection.
    Sperl J, Frankova S, Senkerikova R, Neroldova M, Hejda V, Volfova M, Merta D, Viklicky O, Spicak J, Jirsa M.
    World J Gastroenterol; 2015 May 14; 21(18):5496-504. PubMed ID: 25987772
    [Abstract] [Full Text] [Related]

  • 12. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
    Fateh A, Aghasadeghi MR, Keyvani H, Mollaie HR, Yari S, Hadizade Tasbiti AR, Ghazanfari M, Monavari SH.
    Asian Pac J Cancer Prev; 2015 May 14; 16(5):1873-80. PubMed ID: 25773839
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H, Raza A, Ali K, Khattak JZ, Irfan J, Gill ML.
    Int J Infect Dis; 2015 Jan 14; 30():91-7. PubMed ID: 25462177
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
    Derbala M, Rizk N, Shebl F, Alkaabi S, Eldweik N, John A, Sharma M, Yaqoob R, Almohanadi M, Butt M, Alejji K.
    World J Gastroenterol; 2012 Dec 21; 18(47):7003-8. PubMed ID: 23323000
    [Abstract] [Full Text] [Related]

  • 15. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E, Piekarska A, Koślińska-Berkan E, Omulecka A, Szymańska B, Wójcik K.
    Acta Biochim Pol; 2012 Dec 21; 59(3):333-7. PubMed ID: 22924160
    [Abstract] [Full Text] [Related]

  • 16. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
    Jung YK, Kim JH, Ahn SM, Yang JW, Park SJ, Kim JW, Yeon JE, Kwon OS, Kim YS, Choi DJ, Kim JH, Byun KS.
    J Clin Gastroenterol; 2013 Aug 21; 47(7):644-50. PubMed ID: 23442843
    [Abstract] [Full Text] [Related]

  • 17. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
    Domagalski K, Pawłowska M, Tretyn A, Halota W, Pilarczyk M, Smukalska E, Linkowska K, Grzybowski T.
    Eur J Clin Microbiol Infect Dis; 2013 Jun 21; 32(6):745-54. PubMed ID: 23314745
    [Abstract] [Full Text] [Related]

  • 18. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population.
    Dong ZX, Zhou HJ, Xiang XG, Guo SM, Zhuang Y, Zhao GD, Xie Q.
    J Dig Dis; 2015 Feb 21; 16(2):90-7. PubMed ID: 25312023
    [Abstract] [Full Text] [Related]

  • 19. IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.
    Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, Norkrans G, Söderholm J, Wahlberg T, Wejstål R, Westin J, Hellstrand K.
    J Viral Hepat; 2011 Jul 21; 18(7):e325-31. PubMed ID: 21692944
    [Abstract] [Full Text] [Related]

  • 20. Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.
    Jacobson I, Zeuzem S, Flisiak R, Knysz B, Lueth S, Zarebska-Michaluk D, Janczewska E, Ferenci P, Diago M, Zignego AL, Safadi R, Baruch Y, Abdurakhmanov D, Shafran S, Thabut D, Bruck R, Gadano A, Thompson AJ, Kopit J, McPhee F, Michener T, Hughes EA, Yin PD, Noviello S.
    World J Gastroenterol; 2016 Mar 28; 22(12):3418-31. PubMed ID: 27022224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.